key: cord-0905135-tfhehgxz
authors: Michel, Detlef; Danzer, Karin M.; Groß, Rüdiger; Conzelmann, Carina; Müller, Janis A.; Freischmidt, Axel; Weishaupt, Jochen H.; Heller, Sandra; Münch, Jan; Michel, Manuela; Stamminger, Thomas; Kleger, Alexander; Otto, Markus
title: Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA
date: 2020-09-03
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2020.113965
sha: aca16efbb219753cf4b570d6bee79c12e668e392
doc_id: 905135
cord_uid: tfhehgxz

Pandemic SARS-CoV-2 infection has rapidly developed into a socioeconomic and humanitarian catastrophe. Basic principles to prevent SARS-CoV-2 transmission are social distancing, face masks, contact tracing and early detection of SARS-CoV-2. To meet these requirements, virtually unlimited test capacities delivering results in a rapid and reliable manner are a prerequisite. Here, we provide and validate such a rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA, termed COVID-quick-DET. This straightforward method operates with simple proteinase K treatment and repetitive heating steps with a sensitivity of 94,6 % in head-to-head comparisons with kit-based isolation methods. This result is supported by data obtained from serially diluted SARS-CoV-2 virus stocks. Given its cost- and time-effective operation, COVID-quick-DET might be best suited for countries with general shortage or temporary acute scarcity of resources and equipment.

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

 Simplified SARS-CoV-2 RNA isolation is possible without commercial RNA isolation kits  The method is rapid, reliable and cost-effective, works best on nasopharyngeal swabs  Tracheal secretion appears unsuitable most likely due to high mucus/protein content  Detection threshold is slightly higher compared to kit-based RNA extraction methods  Method could bypass or temporally bridge shortage of resources J o u r n a l P r e -p r o o f

The current pandemic coronavirus has spread rapidly over the world to become the major medical and socioeconomic burden of the current and past era. Infections and deaths continue to rise worldwide: at least 14.481.900 people have been infected so far, and 606.300 humans with Severe-Acute-Respiratory-Syndrome-Corona-Virus-2 (SARS-CoV-2) infection died (status 20.07.2020, 9 am (Mizumoto et al., 2020) . Amongst others, South Korea has conducted most tests worldwide, considered as the basis for rapid disease control. Accordingly, a recent simulation calculated a required daily test capacity between 0.7 to 3.6 tests per thousand residents depending on the mitigation policies in place to contain the disease (Fiore et al., 2020) . Current SARS-CoV-2 tests mostly depend on the costly isolation of viral RNA elements using viral RNA isolation kits from human specimen (Corman et al., 2020) . However, those kits and recently even viral swab kits have become increasingly scarce, thus delaying the provision of SARS-CoV-2 RNA as a starting material for subsequent RT-qPCR (Corman et al., 2020) . Long delivery times and uncertain deliveries per se, particularly into less urbanized country parts further complicate this situation (https://www.the-scientist.com/). Here, we provide a simple, short and fast protocol to extract SARS-CoV-2 RNA from throat swaps and other materials from the respiratory tract without the necessity to use viral RNA isolation kits (referred to as COVID-quick-DET). More than 40.000 patients and health care professionals have been so far routinely tested in our facility using customized total nucleic acid purification kits followed by subsequent SARS-CoV-2-RNA RT-qPCR (Corman et al., 2020;  https://www.who.int/). Out of those, more than 230 specimens have been detected positive for SARS-CoV-2. To operate independently from RNA isolation kits and to accelerate sample processing, we developed COVID-quick-DET: First, a small amount of swab storage solution or the same amount of normal saline applied to resuspend the dry swab via vortexing (1ml normal saline, 5 seconds) were used as an input for subsequent proteinase K treatment.

Specifically, 3 µl proteinase K (20 mg/ml) was placed in the lid of an Eppendorf tube. 80-100

µl of the patient sample was pipetted into the Eppendorf tube. After closing the lids, all samples were pulse-spun for 2-5 seconds at 8000 rpm. This was followed by an incubation of 3 minutes at 56 ° C, then 3 minutes at 95 ° C to inactivate the proteinase. Heating to 56°C or higher has been previously shown to safely also inactive SARS corona virus, which is structurally similar to SARS-CoV-2 (Darnell et al., 2004; Kariwa et al., 2006) . After a short centrifugation step, 5 µl of the sample was then added to the PCR master mix and the RT-PCR is carried out. Primer and probe were published elsewhere by Corman et al. (Corman et al., 2020) todetect the E gene. Confirmation of positive results was provided by proof of ORF1b-nsp14 ; https://www.who.int/). While three samples from asymptomatic individuals did not reach the detection limit, all symptomatic COVID-19 patients could be identified with COVID-quick-DET Fisher´s exact test, two-tailed, not significant, P-value 0.2432; (Figure 1A , gene expression values); COVID-quick-DET sensitivity: 94.64%. We also tested 13 COVID-19 negative specimen with both methods and did not observe any false positive results using COVID-quick-DET method (Fisher´s exact test, two-tailed, not significant, P-value 1.000). We have applied the method for testing clinical staff. All of the approximately 600 employees tested were healthy at the time. All tests were negative (below the detection limit). To the best of our knowledge, none of them was positive when tested with a kit-based viral RNA isolation method during the following 2 to 3 weeks and without evident COVID-19 symptoms. In addition, COVID-quick-DET can be conducted in any laboratory using standard molecular biology laboratory reagents and provides RNA suitable for quantitative PCR analytics within appx. 90 min vs. 280 min kit-based per 100 samples ( Figure 1B) .

Finally, we calculated costs per testing 100 individuals with either method and observed a 100fold reduction (4,50€ vs. 450€; Figure 1C) , a relevant issue in light of an average testing rate of appx. 400.000 tests per week in the accredited laboratories of Germany (https://www.almev.de). Finally, COVID-quick-DET operates equally effective in most material collection devices, and most importantly also in normal saline upon a dry Q-tip swab ( Figure 1D ).

However, COVID-quick-DET did not detect all SARS-CoV-2 true positive human specimen. To better define the detection threshold of our method, we performed serial dilutions of SARS-CoV-2 virus stocks of two strains in medium followed by viral RNA extraction either by COVID-J o u r n a l P r e -p r o o f

Extracted RNA was subjected to RT-qPCR for SARS-CoV-2 ORF1b-nsp14 in the prepared samples. Confirming sensitivity observed for clinical samples, COVID-quick-DET operates reliably across a wide range of viral dilutions (>6 log units), however, the threshold is around 3-4 cycles below the commercial reference RNA extraction method (Figure 1E). Accordingly, the detection limit of COVID-quick-DET is a cycle threshold

COVID-quick-DET clearly has limitations: In our head-to-head tested cohort, this limitation would have led to 5.35 missed patients per 100 truly SARS-CoV-2 infected

Enhancement of PCR Sensitivity and Yield Using Thiol-modified Primers

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV

Containment of future waves of COVID-19: simulating the impact of different policies and testing capacities for contact tracing, testing, and isolation

Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents

White crossed boxes marked with "#" represent the samples giving discrepant results between COVID-quick-DET and the reference method. Samples taken from bronchoalveolar lavages are indicated by asterisk. (B) Time for RNA isolation per 100 samples in minutes. (C) Costs for RNA isolation per 100 samples in Euro. (D) Schematic workflow of tested material compatible with COVID-Quick-DET method and successful qPCR. (E) Detection of SARS-CoV-2 ORF1b-nsp14 in samples prepared by serial dilution of virus stocks of two strains in medium (French-left panel; Dutch-right panel). Viral RNA was either extracted by Qiagen Viral RNA Mini Kit (Qiagen #52906) or prepared by the COVID-quick-DET protocol before being subjected to RT-qPCR as described

This study was supported by the COVID-19 research funding of the state Baden-Wuerttemberg